| Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy? JA Pinto, CS Vallejos, LE Raez, LA Mas, R Ruiz, JS Torres-Roman, ... ESMO open 3 (3), e000344, 2018 | 188 | 2018 |
| Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer JM Araujo, AC Gomez, A Aguilar, R Salgado, JM Balko, L Bravo, F Doimi, ... Scientific reports 8 (1), 4899, 2018 | 121 | 2018 |
| In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies JA Pinto, C Rolfo, LE Raez, A Prado, JM Araujo, L Bravo, W Fajardo, ... Scientific reports 7 (1), 1526, 2017 | 86 | 2017 |
| Barriers in Latin America for the management of locally advanced breast cancer JA Pinto, L Pinillos, C Villarreal-Garza, Z Morante, MV Villarán, G Mejía, ... ecancermedicalscience 13, 897, 2019 | 60 | 2019 |
| Immunotherapy in triple-negative breast cancer: A literature review and new advances GA Valencia, P Rioja, Z Morante, R Ruiz, H Fuentes, CA Castaneda, ... World Journal of Clinical Oncology 13 (3), 219, 2022 | 48 | 2022 |
| Impact of the delayed initiation of adjuvant chemotherapy in the outcome of triple negative breast cancer Z Morante, R Ruiz, JM Araujo, JA Pinto, G de la Cruz-Ku, ... Clinical Breast Cancer 21 (3), 239-246. e4, 2021 | 45 | 2021 |
| A prognostic signature based on three-genes expression in triple-negative breast tumours with residual disease JA Pinto, J Araujo, NK Cardenas, Z Morante, F Doimi, T Vidaurre, ... NPJ genomic medicine 1 (1), 1-7, 2016 | 45 | 2016 |
| Human epidermal growth factor receptor 2–positive breast cancer is associated with indigenous American ancestry in Latin American women KM Marker, VA Zavala, T Vidaurre, PC Lott, JN Vásquez, ... Cancer research 80 (9), 1893-1901, 2020 | 44 | 2020 |
| Anemia como factor pronóstico en pacientes con cáncer V Paitan, C Alcarraz, A Leonardo, G Valencia, R Mantilla, Z Morante, ... Revista Peruana de Medicina Experimental y Salud Publica 35, 250-258, 2018 | 37 | 2018 |
| Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience G De-la-Cruz-Ku, M Luyo, Z Morante, D Enriquez, MG Möller, ... PloS one 15 (8), e0237811, 2020 | 35 | 2020 |
| Repeated observation of immune gene sets enrichment in women with non-small cell lung cancer JM Araujo, A Prado, NK Cardenas, M Zaharia, R Dyer, F Doimi, L Bravo, ... Oncotarget 7 (15), 20282, 2016 | 31 | 2016 |
| Anemia as a prognostic factor in cancer patients V Paitan, C Alcarraz, A Leonardo, G Valencia, R Mantilla, Z Morante, ... Revista Peruana de Medicina Experimental y Salud Publica 35 (2), 250-258, 2018 | 23 | 2018 |
| Neutrophil-to-lymphocyte ratio predicts early mortality in females with metastatic triple-negative breast cancer G de la Cruz-Ku, D Chambergo-Michilot, JS Torres-Roman, P Rebaza, ... PLoS One 15 (12), e0243447, 2020 | 21 | 2020 |
| Post-recurrence survival in triple negative breast cancer. Z Morante, GA De la Cruz Ku, D Enriquez, A Saavedra, M Lujan, R Luque, ... Journal of Clinical Oncology 36 (15_suppl), e13120-e13120, 2018 | 21 | 2018 |
| Status of breast cancer in Latin American: Results of the breast cancer revealed initiative N Ayala, S Barchuk, G Inurrigarro, C Celano, JL Soriano-García, ... Critical Reviews in Oncology/Hematology 181, 103890, 2023 | 20 | 2023 |
| Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy? ESMO Open. 2018; 3: e000344 JA Pinto, CS Vallejos, LE Raez, LA Mas, R Ruiz, JS Torres-Roman, ... Journal of Thoracic Disease. All rights reserved. J Thorac Dis 13 (6), 3816-3826, 2021 | 16 | 2021 |
| Citorreducción óptima en cáncer de ovario avanzado tratado con paclitaxel a dosis densa y carboplatino seguido de cirugía de intervalo en el Instituto Nacional de Enfermedades … C Alcarraz, J Muñiz, L Mas, M Olivera, Z Morante, M Alvarez, R Mantilla, ... Revista Peruana de Medicina Experimental y Salud Pública 35, 46-54, 2018 | 13 | 2018 |
| Lymph node ratio as best prognostic factor in triple‐negative breast cancer patients with residual disease after neoadjuvant chemotherapy GA De la Cruz‐Ku, D Chambergo‐Michilot, B Valcarcel, P Rebaza, ... The breast journal 26 (9), 1659-1666, 2020 | 12 | 2020 |
| Primary cutaneous T-cell lymphoma: experience from the Peruvian National Cancer Institute R Ruiz, Z Morante, R Mantilla, L Mas, L Casanova, HL Gomez Anais brasileiros de dermatologia 92 (5), 649-654, 2017 | 11 | 2017 |
| Breast-conserving surgery vs. total mastectomy in patients with triple negative breast cancer in early stages: a propensity score analysis G De-la-Cruz-Ku, B Valcarcel, Z Morante, MG Möller, LP Rebaza, ... Breast disease 39 (1), 29-35, 2020 | 10 | 2020 |
Henry GomezOncoSalud/AUNA (Lima, Peru)Verified email at gecoperu.org
